Literatur
-
1
Böhmig M, Wiedenmann B, Rosewicz S.
Diagnostik
und Staging des Pankreaskarzinoms.
Dtsch Med Wochenschr.
2001;
126
113-116
-
2
Lowenfels A B, Maisonneueve P, Cavallini G, Ammann R W, Lankisch P G, Andersen J R, DiMagno E P, Andren-Sandberg A, Domellof L.
Pancreatitis
and the risk of pancreatic cancer.
New Engl J Med.
1993;
328
1433-1437
-
3
McDermott R P, Kramer P.
Adenocarcinoma of the
pancreas in four siblings.
Gastroenterology.
1973;
65
137-139
-
4
Reimer P R, Fraumeni J F, Ozols R F, Bender R.
Pancreatic cancer in
father and son.
Lancet.
1977;
1
911-912
-
5
Ghadirian P, Boyle P, Simard A, Baillargeon J, Maisonneuve P, Perret C.
Reported
family aggregation of pancreatic cancer within population-based
case-control study in the Francophone community in Montreal.
Int
J Pancreatol.
1991;
10
183-196
-
6
Hruban R H, Canto M I, Yeo C J.
Prevention
of pancreatic cancer and strategies for management of familial pancreatic
cancer.
Dig Dis Sci.
2001;
19
76-84
-
7
Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M.
Most human carcinomas
of the exocrine pancreas contain mutant c-K-ras genes.
Cell.
1988;
53
549-554
-
8
Goldstein A M, Fraser M C, Struewing P J, Hussassian C J, Ranade K, Zametkin D P, Fontaine L S, Organic S M, Dracopolis N C, Clark W H, Tucker M A.
Increased
risk of pancreatic cancer in melanoma-prone kindreds with p16INK4a
mutations.
New Engl J Med.
1995;
333
970-974
-
9
Lynch H T, Brand R E, Lynch J F, Fusaro R M, Smyrk T C, Goggins M, Kern S E.
Genetic
counseling and testing for germline p16 mutations in two pancreatic
cancer-prone families.
Gastroenterology.
2000;
119
1756-1760
-
10
Goggins M, Schutte M, Lu J, Moskakluk C A, Weinstein C L, Petersen G M, Yeo C J, Jackson C E, Lynch H T, Hruban R H, Kern S E.
Germline BRCA2
gene mutations in patients with apparently sporadic pancreatic carcinomas.
Cancer Res.
1996;
56
5360-5364
-
11
Ozcelik H, Schmocker B, Di Nicola N, Shi X H, Langer B, Moore M, Taylor B R, Narod S A, Darlington G, Andrulis I L, Gallinger S, Redston M.
Germline BRCA2 6174delT
mutations in Ashkenazi Jewish pancreatic cancer patients.
Nature
Genet.
1997;
16
17-18
-
12
Moskaluk C A, Hruban R H, Kern S E.
p16
and K-ras gene mutations in the intraductal precursors of human
pancreatic adenocarcinoma.
Cancer Res.
1997;
57
2140-2143
-
13
DiMagno E P, Reber H A, Tempero M A.
AGA technical
review on the epidemiology, diagnosis, and treatment of pancreatic
ductal adenocarcinoma.
Gastroenterology.
1999;
117
1464-1484
-
14
Witt H, Simon P, Lerch M M.
Genetische Aspekte
der chronischen Pankreatitis.
Dtsch Med Wochenschr.
2001;
126
988-993
-
15
Keim V.
Mutationen
des sekretorischen Trypsininhibitors im Pankreas - Ist
die genetische Ursache der chronischen Pankreatitis jetzt geklärt?.
Z
Gastroenterol.
2001;
39
765-768
-
16
Neglia J P, FitzSimmons S C, Maisonneuev P. et al .
The risk of cancer among patients with cystic
fibrosis.
N Engl J Med.
1995;
332
494-499
-
17
Malats N, Casals T, Porta M, Guarner L, Estivill X, Real F X.
Cystic
fibrosis transmembrane regulator (CFTR) ΔF508 mutation
and 5T allele in patients with chronic pancreatitis and exocrine
pancreatic cancer.
Gut.
2001;
48
70-74
-
18
Lynch H T, Smyrk T C, Watson P, Lanspa S J, Lynch J F, Lynch P M, Cavalieri R J, Boland C R.
Genetics, natural
history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal
cancer: an updated review.
Gastroenterology.
1993;
104
1535-1549
-
19
Lynch H T, Voorhees G J, Lanspa S J, McGreevy P S, Lynch J F.
Pancreatic
carcinoma and hereditary nonpolyposis colorectal cancer: a family
study.
Br J Cancer.
1985;
52
271-273
-
20
Yamamoto H, Itoh F, Nakamura H, Fukushima H, Sasaki S, Perucho M, Imai K.
Genetic and
clinical features of human pancreatic ductal adenocarcinomas with
widespread microsatellite instability.
Cancer Res.
2001;
61
3139-3144
-
21
Brentnall T A, Bronner M P, Byrd D R, Haggitt R C, Kimmey M N.
Early
diagnosis and treatment of pancreatic dysplasia in patients with a
family history of pancreatic cancer.
Ann Intern Med.
1999;
131
247-255
-
22
Hsing A W, Hansson L E, McLaughlin J K, Nyren O, Blot W J, Ekbom A, Fraumeni J F.
Pernicious
anemia and subsequent cancer: a population-based cohort study.
Cancer.
1993;
71
745-750
Dr. med. Yildiz Yildiz
Univ.-Prof. Dr. med. Siegfried Matern
Dr. med. Frank Lammert
Medizinische Klinik III, Universitätsklinikum
der RWTH Aachen
Pauwelsstraße 30
52074 Aachen
Phone: 0241/8088210
Fax: 0241/8082455
Email: flammert@post.klinikum.rwth-aachen.de
